All News
Filter News
Found 808,448 articles
-
aTyr Pharma Slashes 30% of Employees as it Initiates Corporate Restructuring Following ORCA Failure
5/14/2018
Shares of San Diego-based aTyr Pharma are down nearly 20 percent this morning after the company announced a corporate restructuring plan that includes a 30 percent reduction of staff following failures of its preclinical ORCA program. -
Ansun Biopharma closed on a Series A financing round worth $85 million. The company plans to use the funds raised for a Phase III clinical trial of its experimental anti-viral drug, DAS181.
-
Shares of Ziopharm Oncology, Inc. are still sliding after the company announced it was pausing its planned Phase III trial for its lead gene therapy product designed to treat patients with recurrent glioblastoma (rGBM) as a monotherapy and in combination with an immune checkpoint inhibitor.
-
MEI Pharma Grabs $75 Million Private Placement to Drive Registration Study for P13K Inhibitor Pro...
5/14/2018
Shares of MEI Pharma, Inc. are up nearly 9 percent this morning after the company snagged $75 million in a private placement that was led by Vivo Capital and CAM Capital. The funds will be used to treat adults with relapsed or refractory follicular lymphoma with a P13K inhibitor. -
Takeda Reports FY2017 Full Year Results and Issues FY2018 Guidance
5/14/2018
FY2017 performance reflects superior execution Underlying results: Revenue +5.5%, Core Earnings +40.2%, Core EPS +44.8% Takeda will maintain its underlying growth momentum in FY2018
-
FDA approves additional claim for Roche cobas Zika test
5/14/2018
New claim allows for streamlined screening of pooled blood or plasma donations
-
Beam Therapeutics Founded by Gene Editing Pioneers to Create Precision Genetic Medicines with Base Editing
5/14/2018
Beam Therapeutics announced today that it is launching to develop precision genetic medicines
-
Concentric Analgesics Announces Positive Topline Results from Phase 1b Clinical Trial for CA-008 in Post-Surgical Pain
5/14/2018
Clinically Meaningful Reductions in Pain Lasting for a Week
-
Baxter Announces U.S. FDA Clearance of New Spectrum IQ Infusion System
5/14/2018
Designed with Exclusive New Features for Bi-Directional Electronic Medical Records Integration Including Auto-Programming and Auto-Documentation
-
CurveBeam Announces FDA 510(k) Clearance for LineUP Weight Bearing Multi-Extremity CT System
5/14/2018
Compact system enables radiologists and orthopedic specialists to visualize three-dimensional bone detail of the lower extremities while the patient is standing
-
Immunicom's Immunotherapy Product Receives U.S. FDA Breakthrough Device Designation for the Treatment of Cancer
5/14/2018
Immunopheresis™ therapy is a proprietary technology that selectively removes immune inhibitors from a patient's bloodstream potentially enabling their natural immune system to more-effectively attack cancer tumors.
-
Myomo® Application for Medicare Codes Receives Favorable Preliminary Decision
5/14/2018
Myomo is a wearable robotics company.
-
Pharmascience Inc. Launches (Pr)pms-NITROFURANTOIN, First Generic Bioequivalent to MacroBID® Available on the Market, for the Treatment of Urinary Tract Infections
5/14/2018
First generic bioequivalent to MacroBID® on the Canadian market
-
CStone announces first patient dosing with anti-PD-1 antibody CS1003 in Phase I study in Australia
5/14/2018
Second pipeline candidate to enter Phase I studies in Australia within one month
-
Alkahest Announces Initiation of Two Phase 2 Clinical Trials of ALK4290 in Age-Related Macular Degeneration
5/14/2018
Alkahest Inc. is a clinical-stage biotechnology company focused on developing innovative therapies to treat age-related diseases
-
Arrowhead Doses First Hepatitis B Patients in Multiple Dose Portion of Phase 1/2 Study of ARO-HBV
5/14/2018
Arrowhead has also dosed a total of 20 healthy volunteers since the study began on March 27.
-
Lilly to Acquire AurKa Pharma
5/14/2018
Acquisition Expands Lilly Oncology Pipeline with Early-Phase Asset Being Studied in Multiple Tumor Types
-
Dr. Milton L. Lee, Co-Founder and Chief Science Officer of Axcend, will Deliver the Opening Lecture at the 42nd International Symposium on Capillary Chromatography
5/14/2018
Dr. Lee's address on "Novel Column Technologies for Portable Capillary Chromatography" will be presented tomorrow, May 15, at the prestigious conference being held at the Congress Centre in Riva del Garda, Italy; Dr. Lee and Axcend will also spotlight the award-winning, portable Axcend Focus LC high performance liquid chromatography system (HPLC) in booth #26 during the exhibition portion of ISCC42
-
Beam Therapeutics Launched to Develop Harvard Base Editing Technology toward Precision Genetic Medicines
5/14/2018
Harvard innovations enable the correction of single-base mutations in DNA with unprecedented precision and efficiency
-
BMG Pharma: GelX® Approved in Europe for Prevention of Oral Mucositis in Cancer Patients
5/14/2018
BMG Pharma S.r.l., an innovative specialty pharmaceutical company, is pleased to announce the European regulatory approval for its GelX product to be used for the prevention of oral mucositis.